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Abstract
Background: Cinnamon is a spice which has been in use for 1000 of years for its taste, 
condiment, and for its medicinal values. It has a history of medicinal use in China, Egypt, 
and Europe. In traditional medicine, cinnamon is used in respiratory, digestive, and skin 
ailments. It has anti-inflammatory, antibacterial, antidiabetic, antiarthritic, anticlotting, 
and immune regulatory properties. Cinnamon oil is used topically in the treatment of 
certain skin diseases such as acne, eczema, and pimples. In recent times, there has been 
a gradual rise in interest in the use and research on medicinal plants the world over due 
to their safety margin and minimal side and adverse effects. Aim: This paper aims to 
review the available scientific literature and to provide a comprehensive summary on 
the potential medicinal benefits of cinnamon in orofacial disease conditions. A review 
of the scientific literature available on cinnamon conclusively proves its efficacy in the 
management of several ailments including metabolic disorders like diabetes and lifestyle-
associated conditions like hyperlipidemia. Conclusion: A review of its mechanism of 
action indicates its potential therapeutic benefit in the management of various orofacial 
conditions including trigeminal neuralgia and lichen planus. Clinical Significance: 
Cinnamon unfortunately like any medications does have its share of adverse effects and 
reactions, and therefore, its clinical use must be paved with caution and planned clinical 
trials, keeping in mind its potential adverse effects and interactions will result in a more 
standard formulation and protocol for the use of cinnamon as a therapeutic agent.
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Introduction
From the inception of medicine, humankind and healers have 
strived to eliminate disease as a scourge of life. However, this 
panacea is still elusive. Despite medical practice and research 
going on for more than a millennia, we have cure for barely a 
handful of diseases. Immune-mediated diseases, in particular, 
have posed a diagnostic challenge. Our paper attempts to explore 
the available literature on cinnamon as a therapeutic agent and 
hypothesize its beneficial role in the management of immune-
mediated diseases, manifesting in the orofacial region.
History of Cinnamon
From ancient times, cinnamon has been a treasured spice. It finds 
mention in the Bible and has been used not only as a flavoring 
agent but also been used for its embalming properties in ancient 
Egypt. Cinnamon finds great value in Chinese medicine from 
around 2700 BC. The Romans considered cinnamon sacred and 
burnt it at funerals. Cinnamon was the first commodity which 
was traded between countries. It is an aromatic spice that is 
obtained from the inner bark of cinnamon tree.[1]
Cinnamon
Cinnamon is the dry bark of a small evergreen tree belonging to the 
Lauraceae family. There are two varieties of cinnamon; Cinnamomum 
cassia and Cinnamomum verum. C. verum often considered the true 
cinnamon and is originally from Sri Lanka. Other types of cinnamon 
include Cinnamomum tamala, Cinnamomum burmannii, and 
Cinnamomum oliveri. The most important constituents of cinnamon 
are cinnamaldehyde and trans-cinnamaldehyde. These are present 
in the essential oil and contribute to its biological properties, 
antityrosinase activity, and antioxidant activity.
Cinnamomum zeylanicum is the preferred variety of cinnamon 
for medical use since the Journal of Federal Institute has 
specifically stated that this form of cinnamon contains negligible 
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quantities of coumarin. Other forms of cinnamon mainly 
C. cassia also known as Cinnamomum aromaticum or Chinese 
cinnamon were found to contain coumarin beyond tolerable 
limits.[2] Coumarins are phytochemicals with carcinogenic and 
hepatotoxic actions, the mechanism of which is yet to be clearly 
understood.[3]
C. zeylanicum is indigenous to Sri Lanka and parts of South 
India.[4] Trans-cinnamaldehyde, eugenol, and linalool are the 
main components of its bark extract. Several studies are available 
in literature which have demonstrated the health benefits of 
C. zeylanicum, including its antimicrobial properties, ability to 
reduce inflammation, cognitive function enhancement, and 
beneficial role in colonic cancer.[5]
Chemical composition
The chemical composition of cinnamon constitutes of 
cinnamic acid, cinnamaldehyde, tannin, eugenol, coumarin, 
ethyl cinnamate, and linalool, which contributes to the number 
of medicinal properties such as antioxidative, antimicrobial, 
anti-inflammatory, antidiabetic, anticancer, antiseptic, local 
anesthetic, weight reducer, anticlotting, and carminative.[6] 
Cinnamon is available commercially in the form of powders, 
dried barks, bark oils, and capsules.
Antimicrobial activity
Various studies have conclusively proved the antimicrobial 
efficacy of cinnamon. Cinnamon oil has found to be effective 
against Staphylococcus aureus, Enterococcus faecalis, Bacillus 
cereus, Escherichia coli, Pseudomonas aeruginosa, Aspergillus 
flavus, Candida lipolytica, Debaryomyces hansenii, and Candida 
albicans.
S. aureus is found to be a causative agent in angular cheilitis, 
parotitis, stomatitis, and cellulitis. E. faecalis causes endodontic 
infections, periodontitis, and peri-implantitis. C. albicans causes 
oral thrush and candidal leukoplakia. A. flavus causes chronic 
granulomatous sinusitis, cutaneous aspergillosis, wound 
infection, and osteomyelitis.
Volatile oils from cinnamon demonstrated significant activity 
against Streptococcus faecalis.[7] C. zeylanicum is found to be 
effective against C. albicans and can be used in the management 
of oral thrush.[8] C. zeylanicum was found to inhibit the growth 
of S. aureus, which is the etiology in angular cheilitis, parotitis, 
stomatitis, and cellulitis. Moreover, hence, C. zeylanicum extract 
could have a beneficial role in the management of these orofacial 
conditions.[9] C. zeylanicum is also found to be effective against 
Candida glabrata, Candida parapsilosis, Candida krusei, and 
Candida tropicalis, which in the past have demonstrated some 
resistance to conventional antifungal agents.
In addition to this, C. zeylanicum is also proven to demonstrate 
antiparasitic activity.[10]
Anti-inflammatory activity
Extracts from various types of cinnamon have shown anti-
inflammatory properties. C. cassia has been proven to have an 
inhibitory effect on the production of nitric oxide suggestive that 
this substance could be used to counter inflammation [11] Extracts 
of Cinnamomum ramulus show anti-inflammatory activity by 
reducing the production of inducible nitric oxide synthesis, 
cyclooxygenase 2, and nitric oxide in the central nervous 
system, which indicates that this could be used in the prevention 
or treatment of inflammation mediated neurodegenerative 
disorders.[12] This indicates the potential role of cinnamon extract 
in the management of inflammatory disorders of the orofacial 
region and inflammation mediated neurological diseases such as 
postherpetic neuralgia.
Antidiabetic activity
“Insulin potentiating factor” is a substance isolated from 
cinnamon with high potential for modulating the effect of 
cinnamon.[13,14] Naphthalene methyl esters which are again a 
cinnamon derivative facilitate by lowering of blood glucose 
levels. Several other polyphenols derived from cinnamon have 
demonstrated insulin limiting activity.[14]
Murine models have demonstrated reduction in the 
absorption of alanine by cinnamon extract where alanine plays 
a primitive role in gluconeogenesis.[15] The antidiabetic effect of 
cinnamon extract could be attributed to the counteractive action 
on oxidative stress and pro-inflammatory zones in the pancreas, 
thereby protecting the islet cells.[16]
Antioxidant activity
The role of free radicals in the aging process and carcinogenesis 
is well established. Extracts from cinnamon including ether, 
aqueous extracts, and methanolic extracts have proven 
antioxidant activity. The volatile oils of cinnamon show 
significant antioxidant property at concentration ranging from 
100 to 200 parts per million.[17]
Cinnamon extract has proven action in reducing plasma 
lipid peroxidation level which is a biomarker for oxidative stress. 
Cinnamon extract has also found to have potent free radical 
scavenging activity. Given the proven antioxidant activity of 
cinnamon, extracts of the same could play a tangible role in the 
management of potentially malignant disorders plus improving 
their long-term prognosis.
Role of Cinnamon in Neurologic Disorders
Neurological disorders such as Alzheimer’s disease and 
Parkinson’s disease are debilitating diseases which are 
perhaps underemphasized in many developing countries. 
Neurodegenerative disorders are characterized by progressive 
and irreversible loss of neurons.
A thromboxane A2 receptor known as cinnamophilin isolated 
from Cinnamomum philippinensis.[18] A study on cinnamophilin has 
reported to have cured that the ischemic damage in rat brains [19] 
Cinnamon has also proved to regulate the neurotropic factors 
such as brain-derived neurotrophic factors and neurotrophin 3 in 
mice, with its one of the metabolite, sodium benzoate.[20]
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Antilipemic activity
Cinnamon in number of studies is found to be capable of reducing 
the level of low-density lipoproteins cholesterol and triglycerides 
in blood. This suggests the effective role of cinnamon in the 
prevention of number of heart diseases.
The antilipemic activity is credited to cinnamon due to 
the presence of its phenolic compound known as cinnamate. 
Cinnamate has the capability to decrease the level of serum total 
cholesterol and triglyceride concentrations and also to increase 
the high-density lipoproteins cholesterol levels.[21]
Immunomodulatory activity
C. tamala and C. cassia, in particular, have certain procyanidin 
oligomeric compounds which play a significant role in 
immunomodulatory action. Cinnamtannin D1, one of the 
procyanidin oligomeric compounds, reduces the level of 
interferon-γ and interleukin-2 (IL-2) and suppresses the delayed 
hypersensitivity reaction, thereby enhances immunomodulatory 
action.[22] This suggests the beneficial role of cinnamon in the 
administration of autoimmune diseases such as pemphigus, lichen 
planus, recurrent aphthous stomatitis, and lupus erythematosus.
Anticancer activity
Aqueous extracts of cinnamon have proved to inhibit the action 
of vascular endothelial growth factor subtype 2 kinase activity, 
thereby playing an effective role in preventing angiogenesis.[23]
Cinnamaldehyde, an active component of cinnamon, 
has its own significant role in inhibiting angiogenesis. 
2’-hydroxycinnamaldehyde, a chemical which is derived from 
cinnamaldehyde can inhibit the proliferation of tumor.[24] 
Cinnamaldehyde also has an inhibitory action on NF-xB and 
tumor necrosis factor alpha-induced IL-8 which adds additional 
support to cinnamon as antineoplastic agent.[25]
Therapeutic Role of Cinnamon in Orofacial Conditions
Cinnamon as an antimicrobial agent can be used in the treatment 
of angular cheilitis, parotitis, stomatitis, cellulitis, endodontic 
infections, periodontitis, peri-implantitis, oral thrush, candidal 
leukoplakia, chronic granulomatous sinusitis, cutaneous 
aspergillosis, wound infection, and osteomyelitis by inhibiting wide 
range of microorganisms. Cinnamon due to its anti-inflammatory 
potential can be used in the management of inflammation 
mediated neurological diseases such as postherpetic neuralgia. 
Cinnamon also plays a beneficial role in the management of 
autoimmune diseases such as pemphigus, oral lichen planus, 
recurrent aphthous stomatitis, and lupus erythematosus due to 
its immunomodulatory activity. Cinnamon also can prevent oral 
cancer because of its ability to prevent angiogenesis.
Cinnamon dosage and side effects
The daily dosage of cinnamon is 2–4 g/day. Cinnamon >6 g/
day may cause side effects such as sores in lips and mouth, runny 
nose, stomach upset, fatigue, dizziness, redness, and irritation in 
skin and may also cause reduced blood glucose levels.
Conclusion
An attempt has been made to elucidate the therapeutic potential 
of cinnamon extract and postulate its proven and possible 
application in the field of orofacial medicine. Cinnamon is one of 
the many natural resources available with proven benefits in the 
management of diseases. Purity of the extracted compound and 
standardization of the derivative is pivotal to carry out further 
research, keeping in mind the possible adverse effects and drug 
reactions. This will enable one to explore cinnamon derivatives 
as a viable agent in the management of various orofacial disorders 
while negating the pitfalls of synthetic medicaments.
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